Provided by Tiger Trade Technology Pte. Ltd.

Teva Pharmaceutical

37.09
+0.74002.04%
Post-market: 37.440.3500+0.94%16:15 EDT
Volume:2.85M
Turnover:104.95M
Market Cap:43.21B
PE:61.82
High:37.11
Open:36.46
Low:36.06
Close:36.35
52wk High:38.37
52wk Low:18.21
Shares:1.17B
Float Shares:1.09B
Volume Ratio:0.60
T/O Rate:0.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.6000
EPS(LYR):1.21
ROE:9.69%
ROA:5.13%
PB:5.57
PE(LYR):30.65

Loading ...

Aug 07, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 11, 2019

Major Issues Report

Current report, item 5.07
Jun 05, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 03, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
May 02, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 02, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Apr 16, 2018

Correspondence

Apr 16, 2018

Correspondence

Apr 16, 2018

Correspondence

Feb 16, 2018

Correspondence